CytomX Therapeutics (CTMX) PT Lowered to $15 at Nomura/Instinet

February 28, 2020 5:09 AM EST Send to a Friend

Nomura/Instinet analyst Christopher Marai lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CytomX Therapeutics (CTMX) PT Lowered to $15 at Nomura/Instinet

Member Login

Free News Feed